Gaps in Antiamyloid Medication Access for MCI and Dementia

22 Oct 2026 0 comments

Race and ethnicity are tied to who receives antiamyloid drugs for mild cognitive impairment and dementia, even after adjusting for neighborhood vulnerability, a study shows.
Medscape Medical News

Source: Medscape Neurology Published 22 Oct 2026 Imported 22 Oct 2026 Relevancy: Not reviewed

Read the article

Comments

No comments yet.

Unrestricted

All comments are reviewed before being published. Most comments are approved unless they are clearly inappropriate or unsafe.

Comments

Leave a comment